A bigger waistline, coinciding with a higher risk of cardio-metabolic complications in type 2 diabetes patients, suggests that waist measurement is critical for this population….
Read More »AACE: Cardiometabolic Benefit with Investigational Obesity Drug
Two years of treatment with an investigational combination of phentermine plus topiramate (Qnexa, Vivus) resulted in improved cardiometabolic risk factors, in addition to weight loss….
Read More »Sildenafil Improves Diabetic Cardiomyopathy
Known as a treatment for erectile dysfunction, the phosphodiesterase 5A inhibitor also improves diabetic cardiomyopathy….
Read More »CardioTrainer App
Worksmart Labs, Inc. Android/Free This is one app that we have been using for more than 2 years, to record our workouts.
Read More »Diabetes Associated with Higher Risk of Cardiovascular Problems in Men
Researchers at Brigham and Women’s Hospital found that men with type 2 diabetes treated with insulin without a history of CVD were at higher risk for major cardiovascular events compared with men who had a history of CVD….
Read More »Lifting Weights before Cardio Benefits People with Diabetes
People with diabetes may have better blood sugar control during workouts if they lift weights before doing cardio exercise.…
Read More »Diabetic Cardiomyopathy Is the Greatest Mortality Risk for Diabetes Patients
Millions of people with diabetes won’t die from that disease but instead from heart disease.…
Read More »Do Cardiovascular Risks Differ for Men and Women with or without Diabetes?
Type 2 diabetes is associated with greater relative risk of CHD in women than in men, according to The British Regional Heart Study and British Women’s Heart Health Study.…
Read More »Insulin Therapy May Help Reduce Cardiovascular Disease
Diabetes patients are more susceptible to the development of atherosclerosis than non-diabetics and insulin therapy might help repair atherosclerotic lesions in diabetic patients….
Read More »The Safety and Extrapancreatic effects of GLP-1 on cardiovascular tissue, adipose tissue, liver, and kidney
GLP-1 receptors are widely expressed in CV, adipose, hepatic, and renal tissue. High-affinity GLP-1 receptors are present in autonomic nuclei that control CV functions, and have been isolated in rodent and human cardiomyocytes, endothelial cells, and vascular smooth muscle cells….
Read More »